BLOOD, BLOOD PRODUCTS AND PLASMA SEE INCREASED QUALITY AND SAFETY REQUIREMENTS

摘要

For the next few years, experts expect the demand for plasma for fractionation to increase. Human plasma contains proteins that are processed for life-saving medicines - including coagulation factor concentrates -immunoglobulins, albumin and plasma, and is subjected to at least one industrial process, e.g. solvent/detergent plasma. The supply of this valuable 'commodity' essentially depends on two factors: the donor's willingness to donate and the suitability of the blood/plasma donation. Here, the selection of the donor plays an important role, i.e. the registration of their history and the examination of exclusion factors such as neurological disorders, viral infections (HIV, HBV) or drug abuse.